What question did this study set out to answer?

To review the pharmacological properties, clinical efficacy, and safety profile of angiotensin II receptor antagonists for treating hypertension and congestive heart failure.

September 23, 1996Archives of Internal Medicine

Angiotensin II Receptor Inhibition

View Full Paper

Ask AI

Bookmark

Why the study?

Are angiotensin II receptor antagonists safe and efficacious for the treatment of hypertension and congestive heart failure compared to ACE inhibitors?

Population

Patients with hypertension and congestive heart failure

Comparison

Angiotensin II receptor antagonists vs Angiotensin-converting enzyme inhibitors and…

Design

Review

Authors

FMFranz H. MesserliPreventive Cardiology

Discussion

Member takes

Implication

May support ARBs as cough-free alternatives to ACE inhibitors in hypertension; leaves open head-to-head outcomes data in heart failure.

Key Points

To review the pharmacological properties, clinical efficacy, and safety profile of angiotensin II receptor antagonists for treating hypertension and congestive heart failure.
Summarized clinical pharmacology and trial evidence for losartan potassium, the first approved angiotensin II receptor antagonist.
Compared pharmacological mechanisms, receptor selectivity, and adverse effect profiles between angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors.
Angiotensin II receptor antagonists selectively inhibit the angiotensin II type 1 receptor without altering bradykinin metabolism or enhancing prostaglandin synthesis.
Antihypertensive efficacy is equivalent to that of angiotensin-converting enzyme inhibitors, while cough incidence matches placebo rates.
Evidence supports the suitability of these antagonists as potential first-line therapeutic agents for both hypertension and congestive heart failure.

Structured PICO

Are angiotensin II receptor antagonists safe and efficacious for the treatment of hypertension and congestive heart failure compared to ACE inhibitors?

Population

Patients with hypertension and congestive heart failure

Intervention

Angiotensin II receptor antagonists (e.g., losartan potassium)

Comparator

Angiotensin-converting enzyme (ACE) inhibitors and placebo

Outcome

Antihypertensive efficacy and safety (incidence of cough)

Angiotensin II receptor antagonists represent a promising, effective alternative to ACE inhibitors for hypertension and heart failure, notably avoiding the side effect of cough.

Cite This Study

Franz H. Messerli (1996) studied this question.

synapsesocial.com/papers/6a7223596c240de38cdc50a8 https://doi.org/10.1001/archinte.1996.00440160069010

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Angiotensin II Receptor Inhibition

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Angiotensin II Receptor Inhibition

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider